Latest antibodies Stories
MONROVIA, Calif., Nov. 3, 2014 /PRNewswire/ -- Xencor, Inc.
Focusing development on rare autoimmune disorder IgG4-related disease (IgG4-RD) MONROVIA, Calif., Oct. 28, 2014 /PRNewswire/ -- Xencor, Inc.
Deal Expands Immuno-Oncology Product Discovery and Development Program and Aims to Accelerate Development of Oncology Therapeutics with Compelling Patient Benefit SOUTH SAN FRANCISCO,
Ebola detection kits for humans and animals are now possible using ADI antibody or antigen ELISA kits with results in less than 2 hours.
Broad Bi-Specific Antibody Collaboration Now Includes Targets that Could Lead to New Cancer Immunotherapies INDIANAPOLIS and VANCOUVER, Oct. 22, 2014 /CNW/ - Zymeworks Inc.
PhosImmune and PureMHC Working Together On Immunotherapies for Cancer CHARLOTTESVILLE, Va. and AUSTIN, Texas, Oct. 22, 2014 /PRNewswire/ -- PhosImmune Inc.
PLYMOUTH MEETING, Pa., Oct. 21, 2014 /PRNewswire/ -- Inovio Pharmaceuticals, Inc.
Patent Provides Coverage for Lpath's Anti-S1P Antibody in Europe SAN DIEGO, Oct. 20, 2014 /PRNewswire/ -- Lpath, Inc.
-- CIAO!(TM) Technology Maximizes Selectivity of Conditionally Active Antibodies -- SAN DIEGO, Oct.
New cutting-edge report “Global Cancer Monoclonal Antibodies Market & Pipeline Insight” worked out by Kuick Research is now available at MarketPublishers.com. London,
- A person or thing gazed at with wonder or curiosity, especially of a scornful kind.
More Images (1 images) »